ID   RHG32_MOUSE             Reviewed;        2089 AA.
AC   Q811P8; B9EHJ8; Q6A010;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   07-APR-2021, entry version 144.
DE   RecName: Full=Rho GTPase-activating protein 32;
DE   AltName: Full=Brain-specific Rho GTPase-activating protein;
DE   AltName: Full=GAB-associated Cdc42/Rac GTPase-activating protein;
DE   AltName: Full=GC-GAP;
DE   AltName: Full=Rho-type GTPase-activating protein 32;
DE   AltName: Full=Rho/Cdc42/Rac GTPase-activating protein RICS;
DE   AltName: Full=RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling;
DE   AltName: Full=p200RhoGAP;
DE   AltName: Full=p250GAP;
GN   Name=Arhgap32; Synonyms=Grit, Kiaa0712, Rics;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=C57BL/6J;
RX   PubMed=12819203; DOI=10.1074/jbc.m304594200;
RA   Zhao C., Ma H., Bossy-Wetzel E., Lipton S.A., Zhang Z., Feng G.S.;
RT   "GC-GAP, a Rho family GTPase-activating protein that interacts with
RT   signaling adapters Gab1 and Gab2.";
RL   J. Biol. Chem. 278:34641-34653(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1584-2089.
RC   TISSUE=Fetal brain;
RX   PubMed=15368895; DOI=10.1093/dnares/11.3.205;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Seino S., Nishimura M., Kaisho T., Hoshino K., Kitamura H.,
RA   Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: IV.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 11:205-218(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [6]
RP   ALTERNATIVE SPLICING (ISOFORMS 1 AND 2), INTERACTION WITH CTTNB1; GRIN2B;
RP   DLG4 AND CDH2, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL
RP   STAGE, AND DOMAIN PX.
RX   PubMed=17663722; DOI=10.1111/j.1365-2443.2007.01101.x;
RA   Hayashi T., Okabe T., Nasu-Nishimura Y., Sakaue F., Ohwada S., Matsuura K.,
RA   Akiyama T., Nakamura T.;
RT   "PX-RICS, a novel splicing variant of RICS, is a main isoform expressed
RT   during neural development.";
RL   Genes Cells 12:929-939(2007).
RN   [7]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=12454018; DOI=10.1074/jbc.m207789200;
RA   Moon S.Y., Zang H., Zheng Y.;
RT   "Characterization of a brain-specific Rho GTPase-activating protein,
RT   p200RhoGAP.";
RL   J. Biol. Chem. 278:4151-4159(2003).
RN   [8]
RP   FUNCTION, INTERACTION WITH CTTNB1; GRIN2B; DLG4 AND CDH2, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12531901; DOI=10.1074/jbc.m208872200;
RA   Okabe T., Nakamura T., Nishimura Y.N., Kohu K., Ohwada S., Morishita Y.,
RA   Akiyama T.;
RT   "RICS, a novel GTPase-activating protein for Cdc42 and Rac1, is involved in
RT   the beta-catenin-N-cadherin and N-methyl-D-aspartate receptor signaling.";
RL   J. Biol. Chem. 278:9920-9927(2003).
RN   [9]
RP   INTERACTION WITH GRIN2B, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12857875; DOI=10.1091/mbc.e02-09-0623;
RA   Nakazawa T., Watabe A.M., Tezuka T., Yoshida Y., Yokoyama K., Umemori H.,
RA   Inoue A., Okabe S., Manabe T., Yamamoto T.;
RT   "p250GAP, a novel brain-enriched GTPase-activating protein for Rho family
RT   GTPases, is involved in the N-methyl-d-aspartate receptor signaling.";
RL   Mol. Biol. Cell 14:2921-2934(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH CDC42, TISSUE SPECIFICITY, AND DISRUPTION
RP   PHENOTYPE.
RX   PubMed=16716191; DOI=10.1111/j.1365-2443.2006.00966.x;
RA   Nasu-Nishimura Y., Hayashi T., Ohishi T., Okabe T., Ohwada S., Hasegawa Y.,
RA   Senda T., Toyoshima C., Nakamura T., Akiyama T.;
RT   "Role of the Rho GTPase-activating protein RICS in neurite outgrowth.";
RL   Genes Cells 11:607-614(2006).
RN   [11]
RP   FUNCTION, INTERACTION WITH RASA1, AND MUTAGENESIS OF ARG-58.
RX   PubMed=17272280; DOI=10.1074/jbc.m609375200;
RA   Shang X., Moon S.Y., Zheng Y.;
RT   "p200 RhoGAP promotes cell proliferation by mediating cross-talk between
RT   Ras and Rho signaling pathways.";
RL   J. Biol. Chem. 282:8801-8811(2007).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-709; SER-732; SER-738;
RP   SER-852; SER-856; SER-952 AND SER-1588, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Kidney, Pancreas, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [14]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1526; ARG-1536 AND ARG-2039, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, and Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [15]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH GPHN.
RX   PubMed=27609886; DOI=10.1126/science.aag0821;
RA   Uezu A., Kanak D.J., Bradshaw T.W., Soderblom E.J., Catavero C.M.,
RA   Burette A.C., Weinberg R.J., Soderling S.H.;
RT   "Identification of an elaborate complex mediating postsynaptic
RT   inhibition.";
RL   Science 353:1123-1129(2016).
CC   -!- FUNCTION: GTPase-activating protein (GAP) promoting GTP hydrolysis on
CC       RHOA, CDC42 and RAC1 small GTPases. May be involved in the
CC       differentiation of neuronal cells during the formation of neurite
CC       extensions. Involved in NMDA receptor activity-dependent actin
CC       reorganization in dendritic spines. May mediate cross-talks between
CC       Ras- and Rho-regulated signaling pathways in cell growth regulation.
CC       Isoform 2 has higher GAP activity. {ECO:0000269|PubMed:12454018,
CC       ECO:0000269|PubMed:12531901, ECO:0000269|PubMed:12819203,
CC       ECO:0000269|PubMed:16716191, ECO:0000269|PubMed:17272280}.
CC   -!- SUBUNIT: Interacts with NTRK1 (via cytoplasmic domain); the interaction
CC       is independent of the phosphorylation state of NTRK1 (By similarity).
CC       Interacts with SHC3 (via SH2 domain) (By similarity). Interacts with
CC       RASA1 (via SH3 domain); the interaction is necessary for the Ras
CC       activation and cell transforming activities of ARHGAP32. Interacts with
CC       GAB1 and GAB2. Interacts with CRK and CRKL. Found in a complex with
CC       CRKL and BCAR1; upon EGF stimulation BCAR1 may be replaced by EGFR (By
CC       similarity). Interacts with NCK1 (via SH3 domain); NCK1 recruits
CC       phosphorylated BCAR1 to the complex. Isoform 2 interacts with FYN; the
CC       interaction appears to be dependent on tyrosine phosphorylation of
CC       ARHGAP32 (By similarity). Interacts with EGFR; the interaction requires
CC       EGF stimulation and is increased by SHC3. Interacts with CDC42; the
CC       interaction requires constitutively active CDC42. Interacts with
CC       CTNNB1, DLG4, CDH2 and GRIN2B (By similarity) (PubMed:12531901,
CC       PubMed:12857875, PubMed:16716191, PubMed:17272280, PubMed:17663722).
CC       Interacts with GPHN (PubMed:27609886). {ECO:0000250|UniProtKB:A7KAX9,
CC       ECO:0000269|PubMed:12531901, ECO:0000269|PubMed:12857875,
CC       ECO:0000269|PubMed:16716191, ECO:0000269|PubMed:17272280,
CC       ECO:0000269|PubMed:17663722, ECO:0000269|PubMed:27609886}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, synapse, postsynaptic density
CC       {ECO:0000269|PubMed:12531901, ECO:0000269|PubMed:27609886}. Cell
CC       projection, dendritic spine {ECO:0000269|PubMed:12531901}. Cytoplasm,
CC       cell cortex {ECO:0000250|UniProtKB:A7KAX9}. Endosome membrane
CC       {ECO:0000269|PubMed:17663722}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:17663722}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:17663722}. Membrane {ECO:0000250|UniProtKB:A7KAX9}.
CC       Note=Association to membrane via PX domain (By similarity). Associated
CC       with cortical actin in undifferentiated neuroblastoma cells, but
CC       localized to dendritic spine and postsynaptic density after
CC       differentiation (PubMed:12531901). Colocalizes with EGFR at the cell
CC       membrane upon EGF treatment (By similarity). Colocalizes with GAB2 at
CC       the cell membrane (By similarity). {ECO:0000250|UniProtKB:A7KAX9,
CC       ECO:0000269|PubMed:12531901}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PX-RICS;
CC         IsoId=Q811P8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q811P8-2; Sequence=VSP_034937;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 2 are highly expressed in
CC       brain, specially in cortex, corpus striatum, hippocampus and thalamus.
CC       Low levels in cerebellum, colon, small intestine, and kidney.
CC       {ECO:0000269|PubMed:12454018, ECO:0000269|PubMed:12531901,
CC       ECO:0000269|PubMed:12819203, ECO:0000269|PubMed:12857875,
CC       ECO:0000269|PubMed:16716191, ECO:0000269|PubMed:17663722}.
CC   -!- DEVELOPMENTAL STAGE: Isoform 1 is detectable by embryonic day 13,
CC       whereas isoform 2 is detected postnatally.
CC       {ECO:0000269|PubMed:12819203, ECO:0000269|PubMed:17663722}.
CC   -!- DOMAIN: The N-terminal PX domain interacts specifically with
CC       phosphatidylinositides. {ECO:0000269|PubMed:17663722}.
CC   -!- PTM: Isoform 2 is phosphorylated on multiple tyrosine residues by FYN
CC       (By similarity). Phosphorylated tyrosine residues undergo
CC       dephosphorylation after stimulation of NMDA receptors. Phosphorylated
CC       in vitro by CaMK2 in the presence of calmodulin and calcium; which
CC       inhibits GAP activity. {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Mice are fertile but display abnormal neurite
CC       growth. {ECO:0000269|PubMed:16716191}.
CC   -!- SIMILARITY: Belongs to the PX domain-containing GAP family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY194286; AAO43676.1; -; mRNA.
DR   EMBL; AC134607; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC132390; AAI32391.1; -; mRNA.
DR   EMBL; BC138042; AAI38043.1; -; mRNA.
DR   EMBL; AK173008; BAD32286.1; -; mRNA.
DR   CCDS; CCDS22951.3; -. [Q811P8-2]
DR   CCDS; CCDS57666.1; -. [Q811P8-1]
DR   RefSeq; NP_001182561.1; NM_001195632.1. [Q811P8-1]
DR   RefSeq; NP_796353.3; NM_177379.4. [Q811P8-2]
DR   SMR; Q811P8; -.
DR   BioGRID; 237045; 14.
DR   CORUM; Q811P8; -.
DR   IntAct; Q811P8; 7.
DR   MINT; Q811P8; -.
DR   STRING; 10090.ENSMUSP00000133898; -.
DR   iPTMnet; Q811P8; -.
DR   PhosphoSitePlus; Q811P8; -.
DR   SwissPalm; Q811P8; -.
DR   jPOST; Q811P8; -.
DR   PaxDb; Q811P8; -.
DR   PRIDE; Q811P8; -.
DR   ProteomicsDB; 255209; -. [Q811P8-1]
DR   ProteomicsDB; 255210; -. [Q811P8-2]
DR   Antibodypedia; 51352; 90 antibodies.
DR   Ensembl; ENSMUST00000168954; ENSMUSP00000128448; ENSMUSG00000041444. [Q811P8-2]
DR   Ensembl; ENSMUST00000174641; ENSMUSP00000133898; ENSMUSG00000041444. [Q811P8-1]
DR   Ensembl; ENSMUST00000182802; ENSMUSP00000138145; ENSMUSG00000041444. [Q811P8-2]
DR   GeneID; 330914; -.
DR   KEGG; mmu:330914; -.
DR   UCSC; uc009orv.2; mouse. [Q811P8-1]
DR   CTD; 9743; -.
DR   MGI; MGI:2450166; Arhgap32.
DR   eggNOG; KOG1449; Eukaryota.
DR   eggNOG; KOG3564; Eukaryota.
DR   GeneTree; ENSGT00940000154313; -.
DR   HOGENOM; CLU_002754_0_0_1; -.
DR   InParanoid; Q811P8; -.
DR   OMA; YVPHPKP; -.
DR   OrthoDB; 1300981at2759; -.
DR   PhylomeDB; Q811P8; -.
DR   TreeFam; TF351451; -.
DR   Reactome; R-MMU-194840; Rho GTPase cycle.
DR   BioGRID-ORCS; 330914; 2 hits in 53 CRISPR screens.
DR   ChiTaRS; Arhgap32; mouse.
DR   PRO; PR:Q811P8; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; Q811P8; protein.
DR   Bgee; ENSMUSG00000041444; Expressed in cingulate cortex and 246 other tissues.
DR   ExpressionAtlas; Q811P8; baseline and differential.
DR   Genevisible; Q811P8; MM.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:MGI.
DR   GO; GO:0005938; C:cell cortex; IDA:MGI.
DR   GO; GO:0043197; C:dendritic spine; IEA:UniProtKB-SubCell.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0001650; C:fibrillar center; ISO:MGI.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:MGI.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0014069; C:postsynaptic density; IDA:UniProtKB.
DR   GO; GO:0005096; F:GTPase activator activity; ISO:MGI.
DR   GO; GO:1901981; F:phosphatidylinositol phosphate binding; IEA:InterPro.
DR   GO; GO:0007266; P:Rho protein signal transduction; ISO:MGI.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IBA:GO_Central.
DR   CDD; cd07298; PX_RICS; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 3.30.1520.10; -; 1.
DR   InterPro; IPR042139; PX_ARHGAP32.
DR   InterPro; IPR036871; PX_dom_sf.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   SUPFAM; SSF64268; SSF64268; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell projection; Cytoplasm;
KW   Endoplasmic reticulum; Endosome; Golgi apparatus; GTPase activation;
KW   Membrane; Methylation; Phosphoprotein; Reference proteome; SH3 domain;
KW   Synapse.
FT   CHAIN           1..2089
FT                   /note="Rho GTPase-activating protein 32"
FT                   /id="PRO_0000345204"
FT   DOMAIN          131..245
FT                   /note="PX; atypical"
FT   DOMAIN          259..321
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          372..567
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   REGION          1395..1714
FT                   /note="Interaction with GAB2"
FT                   /evidence="ECO:0000250"
FT   REGION          1688..2089
FT                   /note="Interaction with FYN"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        1033..1038
FT                   /note="Poly-Pro"
FT   COMPBIAS        1309..1314
FT                   /note="Poly-Pro"
FT   MOD_RES         706
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A7KAX9"
FT   MOD_RES         709
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         732
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         738
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         852
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         856
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         892
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A7KAX9"
FT   MOD_RES         952
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1206
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A7KAX9"
FT   MOD_RES         1526
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         1536
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         1588
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         2039
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   VAR_SEQ         1..349
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12819203,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_034937"
FT   MUTAGEN         58
FT                   /note="R->K: Does not affect RhoA or CDC42 activity."
FT                   /evidence="ECO:0000269|PubMed:17272280"
SQ   SEQUENCE   2089 AA;  229719 MW;  C7C4BD904D903F02 CRC64;
     METESETSSL GDDSVFWLDC EGVTQLTDGD EEEREESFRK MKSSIHSEED DFVPELHRNV
     HPRERPDWEE TLSAMARGAD VPEIPGDLTL KSCGSTASTK VKHVKKLPFT KGHFPKMAEC
     AHFHYENVEF GSIQLSLSEE QNEVMKNGCE SKELVYLVQI ACQGKSWIVK RSYEDFRVLD
     KHLHLCIYDR RFSQLTELPR SDVLKDSPES VTQMLTAYLS RLSTIAGNKI NCGPALTWME
     IDNKGNHLLV HEESSINTPA VGAAHVIKRY TARAPDELTL EVGDIVSVID MPPKVLSTWW
     RGKHGFQVGL FPGHCVELIN QKVPQSVTNS VPKPVSKKHG KLITFLRTFM KSRPTKQKLK
     QRGILKERVF GCDLGEHLLN SGFEVPQVLQ SCTAFIERYG IVDGIYRLSG VASNIQRLRH
     EFDSEHVPDL TKEPYVQDIH SVGSLCKLYF RELPNPLLTY QLYEKFSDAV SAATDEERLI
     KIHDVIQQLP PPHYRTLEFL MRHLSLLADY CSITNMHAKN LAIVWAPNLL RSKQIESACF
     SGTAAFMEVR IQSVVVEFIL NHVDVLFSGK ISAVMQEGAA SLSRPKSLLV SSPSTKLLTL
     EEAQARTQAQ VSSPIVTENK YIEVGEGPAA LQGKFHTVIE FPLERKRPQN KMKKSPVGSW
     RSFFNLGKSS SVSKRKLQRN ESEPSEMKAM ALKGGRAEGT LRSAKSEESL TSLHAVDGDS
     KLFRPRRPRS SSDALSASFN GDVLGNRCNS YDNLPHDNES EEEVGLLHIP ALVSPHSAED
     VDLSPPDIGV ASLDFDPMSF QCSPPKAESE CLESGASFLD SLGYTRDKLS PSKKDAEAGG
     SQSQTPGSTA SSEPVSPVQE KLSPFFTLDL SPTDDKSSKP SSFTEKVVYA FSPKIGRKLS
     KSPSMNISEP ISVTLPPRVS EVIGTVSNTV AQNASPTSWD KSVEERDVIN RSPTQLQLGK
     MKAGEREAQE TCEPEAQPLE QGAAEEVELP GTEERPVLSS QSKAVPSGQS QTGAVTHDPP
     QDPVPVSSVS LIPPPPPPKN VARMLALALA ESAQQASSQT LKRPGASQAG CTSYGDTAVV
     PSEEKLPSSY SSLTLDKTCF QTDRPAEQFH PQINGLGNCN QPLPEAAAMG GPTQSNTTDS
     GEQLHQVDLI GNSLHRNHIS GDPEKARSTS APLTDSEKSD DHGSFPEDHA GKSSVSTVSF
     LEQDQSPLHF SCGDQPLSYL GTSVDKPHHS SELTDKSPMP STLPRDKAHH PLSGSPEENS
     STATMAYMMA TPARAEPSNS EASRVLAEQP SAADFVAATL QRTHRTNRPL PPPPSQRPAE
     QPPVVGQVQE APSIGLNNSH KVQGTAPAPE RPPESRAMGD PAPIFLSDGT AAAQCPMGAS
     APQPGLPEKV RESSRAPPLH LRAESFPGHS CGFAAPVPPT RTMESKMAAA LHSSAADATS
     SSNYHSFVPS SASVDDVMPV PLPVSQPKHA SQKIAYSSFA RPDVTAEPFG PENCLHFNMT
     PNCQFRPQSV PPHHNKLEPH QVYGARSEPP ASMGPRYNTY VAPGRNMSGH HSKPCSRVEY
     VSSLGSSVRN PCCPEDILPY PTIRRVQSLH APPPSMIRSV PISRTEVPPD DEPAYCPRPV
     YQYKPYQSSQ ARSDYHVTQL QPYFENGRVH YRYSPYSSSS SSYYSPEGAL CDVDAYGTVQ
     LRPLHRLSSR DFAFYNPRLQ GKNVYNYAGL PPRPRANATG YFSGNDHNVV TMPPTADGKH
     TYTSWDLEDM EKYRMQSIRR ESRARQKVKG PIMSQYDNMT PAVQEDLGGI YVIHLRSKSD
     PGKTGLLSVA EGKEGRHPAK AVSPEGDERF YRKHPESEFD RAHHHGGYGS TQAEKPSLPQ
     KQSSLRNRKL HDMGCSLPEH RAHQEASHRQ LCESKNGPPY PQGAGQLDYG SKGMPDTSEP
     SNYHNSGKYM TSGQGSLTLN HKEVRLPKDL DRPRARQPPG PEKHSRDCYK EEEHFSQSMV
     PPPKPERSHS LKLHHTQNLE RDPSVLYQYQ THSKRQSSMT VVSQYDNLED YHSLPQHQRG
     GFGGAGMGAY VPSGFVHPQS RTYATALGQG AFLPTELSLP HPDTQIHAE
//
